BRAF and melanoma: Binimetinib (Mektovi, BNB), a MEK inhibitor, and encorafenib (Braftovi, ENF), a BRAF inhibitor, are two orally bioavailable drugs established by Array BioPharma that are used for treating melanoma (Figure 1).